Metformin use is associated with reduced odds of new-onset International Classification of Diseases (ICD) coding of ...

A deep learning model may be able to outperform ophthalmologists in predicting neovascular age-related macular degeneration (nAMD) recurrence. Recurrence of neovascular age-related macular ...

New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...

Please provide your email address to receive an email when new articles are posted on . Age-related macular degeneration (AMD) is the fourth most common cause of blindness globally and the leading ...

Please provide your email address to receive an email when new articles are posted on . Contrary to expectations, more patients with neovascular age-related macular degeneration undergoing longer ...

BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those who ...

Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape ...

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III ...

Optometrists' ability to classify retinal lesions for re-treatment decisions regarding quiescent neovascular age-related macular degeneration (nAMD) is not inferior to that of ophthalmologists, ...

The study examined patients who were treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) compounds for their nAMD. A total of 76 patients (92 eyes) were followed for at least ...